NCT04097327

Effect of Ectoin Dermatitis Cream 7% on Skin Hydration and Skin Barrier Function

Effect of Ectoin Dermatitis Cream 7% (EHK02) on Skin Hydration and Skin Barrier Function in Patients With Atopic Dermatitis: a Prospective, Clinical Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 35 (actual)
• Sponsor: Bitop AG · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The aim of this prospective, uncontrolled clinical study is to evaluate the clinical effect of Ectoin® Dermatitis Cream-EHK02 on skin hydration and transepidermal water loss (TEWL) in subjects with atopic dermatitis after single and multiple applications. Furthermore, data concerning the subjective impression of the study preparation should be collected.

Detailed description

The principle mode of Ectoin is based on the physical interaction of this compatible solute with water. Ectoin® Dermatitis Cream 7% (EHK02) is able to build an Ectoin® Hydro Complex on the skin providing an effective protection against external stress factors, stabilizing the skin barrier and moisturizing the dry skin. In former studies, it has been shown that it can be used for the symptomatic treatment of atopic dermatitis. This study should confirm the efficacy and safety of EHK02.

Conditions

• Atopic Dermatitis Eczema

Interventions

Type	Name	Description
OTHER	Ectoin Dermatitis Cream 7% (EHK02)	Application of Ectoin Dermatitis Cream in accordance with the instructions for use

Timeline

• Start date: 2019-08-23
• Primary completion: 2019-12-31
• Completion: 2019-12-31
• First posted: 2019-09-20
• Last updated: 2020-01-10

Locations

1 site across 1 country: Germany